NCT00881244View on ClinicalTrials.gov

Study of AS1411 in Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

February 28, 2007

Conditions

Advanced Solid Tumors

Interventions

DRUG

AS1411

I.v. 4-7 days, 1-40 mg/kg/day

Trial Locations (1)

40202

James Graham Brown Cancer Center, University of Louisville, Louisville

Sponsors

Lead Sponsor

Antisoma Research

All Listed Sponsors

lead

Antisoma Research

INDUSTRY

NCT00881244 - Study of AS1411 in Advanced Solid Tumours | Biotech Hunter | Biotech Hunter